Serono Discontinues Trial Programs
Serono announced the discontinuation of two phase 3 clinical trial programs; onercept (recombinant tumor necrosis factor binding protein) in moderate-to-severe psoriasis and…
network
Serono announced the discontinuation of two phase 3 clinical trial programs; onercept (recombinant tumor necrosis factor binding protein) in moderate-to-severe psoriasis and…
The twin Mars rovers, Spirit and Opportunity, have had their mission extended by 18 months, spokespeople from NASA revealed yesterday.
Forest Laboratories announced that it expects its earnings for the fiscal 2005 fourth quarter ended March 31, 2005 to be lower than previous Company guidance and current First Call mean estimate.
At a cable television conference on Monday, Google co-founder Larry Page indicated the mildly maligned Google Video is going to begin solicitation of personal videos from people who want to contribute.
IBM and Network Appliance announced a strategic storage relationship to drive information on demand solutions and to expand IBM's portfolio of storage solutions...
Noven Pharmaceuticals announced positive preliminary results from clinical trials of its methylphenidate transdermal system (MTS)...